What is Anemia of Prematurity?
All newborn infants manifest a decrease in hemoglobin. In uterus, the tissue is in relatively hypoxic state whereas after birth there is a relatively hyperoxic state. This leads to increased oxygen concentration tissue which leads to decrease in erythropoietin concentration.
In the term infant, this physiological anemia is observed 8-12 weeks after birth.
Anemia of prematurity is an exaggerated, pathologic response of the preterm infant to this change.
Anemia of prematurity is a normocytic, normochromic, hyporegenerative anemia characterized by a low serum erythropietin. Nutritional deficiencies of iron, vitamin E, vitamin B-12, and folate may exaggerate the degree of anemia.
Anemia of prematurity resolves in many premature infants within 3-6 months of birth.
In others, however, medical care is required.
The risk of anemia of prematurity is inversely related to gestational maturity and birthweight.
Causes of Anemia of Prematurity
Three factors are responsible for the development of anemia of prematurity
- Inadequate red blood cell production,
- Shortened red blood cell life span
- Blood loss.
Inadequate RBC production
Erythropoietin is synthesized in fetal liver but gradually shifts toward the kidneywith increase in gestational age. However, liver remains the major source of erythropoietin till the end of gestation.
Fetal erythrocytes are first synthesized in liver and then moves to bone marrow gradually so that by 40 weeks of gestation, bone marrow is center for erythropoiesis.
There is a difference between erythropoietin produced by liver and kidney in level of stimulus required for their production.
Anemia and hypoxia required to stimulate erythropoietin production is far greater for the fetal liver than for the fetal kidney. Liver may not be stimulated for erythropoietin production until the hemoglobin concentration is 6-7 g/dL is reached.
Moreover, erythropoietin, endogenously produced or exogenously administered is rapidly eliminated by neonates, therefore leading to lesser stimulation of bone marrow for production of red blood cells.
Deficiency of iron or other substrate or co-factors required for red blood cell production would lead to inefficient production. Moreover, rapid growth of infant may prevent the appropriate increase in hemoglobin concentration as the demand keeps continuously rising.
Shortened Red Blood Cell life Span or Hemolysis
Adult red blood celss circulated for 100-120 days. Life span of a neonatal red blood cells is only one half to two thirds that of an adult red blood cells. However, red blood cells of immature infants may survive only 35-50 days due to various factors of formation and metabolism.
This further contributes to development of anemia.
Any blood loss during delivery either due to fetal-placental transfer, repeated sampling etcetra may contribute to anemia.
In contrast, delayed cord clamping so as to let more blood pass to fetus from the placenta may lessen the degree of anemia of prematurity.
Presentation of Anemia of Prematurity
- Poor weight gain despite adequate caloric intake
- Tachycardia – increase in heart rate
- Tachypnea – increase in breathing rate
- flow murmurs
- Decreased activity and lethargy
- difficulty with oral feeding
There could be increase in in apneic [stoppage of breathing] and bradycardic [decrease in heart rate] episodes.
Increased cellular anaerobic metabolism may lead to accumulation of lactic acidosis.
Complete Blood Count
It generally shows
- Low hemoglobin values, usually <10g/dL, may reach as low as 6-7 g/dL
- White blood cell count is normal
- Platelet values are normal in anemia of prematurity. Low hemoglobin values, below 10 g/dL, are found.
- Red blood cell indices are normal ( normochromic, normocytic) for age.
Relative to the degree of anemia is considered, reticulocyte count is low. If reticulocyte count is elevated, it is not most likely to be anemia of prematurity.
Peripheral Blood Film
Red blood cell morphology is normal. Prominence of red blood precursor may be visualized.
Coombs test is important to ensure an immune-mediated hemolytic process related to maternal-fetal blood group incompatibility is not present. Rh typing of the mother and child should be done as well.
Serum bilirubin if elevated would suggest an hemolytic type of anemia.
Raised lactic acid levels may guide the need for blood transfusion.
Management of Anemia of Prematurity
As most of the newborns are not symptomatic, observation is indicated in most of the cases who do not have symptoms, are not very ill and are receiving adequate nutrition.
Supportive nutritional treatment like vitamin E, vitamin B-12, folate, and iron can be supplemented.
Hematocrit levels are checked periodically till the levels rise.
Packed red blood cell transfusions
Packed red blood cell transfusions are the mainstay of therapy in patients who require transfusion.
The frequency of blood transfusion varies with gestational age and degree of illness.
There are many problems associated with blood transfusions. These areHematological complications
- Immunologic complications
- Metabolic complications
- Late onset necrotizing enterocolitis
- Infection (hepatitis, cytomegalovirus, human immunodeficiency virus, syphilis)
- Fluid overload and electrolyte imbalances
- Posttransfusion graft versus host disease
Therefore, number of transfusions and number of donors should be reduced as much as possible.
When required, it becomes pertinent to discuss the need for transfusion with family of child and risk associated therein, the advantages and disadvantages of erythropoietin administration.
How to Reduce Donor Number for Transfusion
Infants may be assigned a specific unit of blood from single donor which would suffice for treatment. This limits exposure to single donoe
Recombinant Erythropoietin Treatment
Subcutaneous administration of erythropoietin is preferred because intravenous administration leads to increased loss in the urine.
Studies have suggested an association between erythropoietin administration and retinopathy of prematurity.
Erythropietin treatment protocol is yet to be devised and still it is not accepted as standard therapy.
rd therapy for an infant with anemia of prematurity.
Epoetin alfa is used to stimulate erythropoiesis and decrease the need for erythrocyte transfusions in high-risk preterm neonates. It induces the release of reticulocytes from bone marrow into the bloodstream.
Iron, folate andvitamin E are prescribed, as needed.
Get more Health & Medicine Articles like this
Subscribe & Get Updates sent to your email inbox.
Thank you for subscribing.
Something went wrong.